International Stem Cell (ISCO) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ISCO Annual Balance Sheets →
The data below summarizes International Stem Cell's balance sheet position from Jun 30 2025 to Jun 30 2026, enabling a period-by-period comparison of financial strength.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent1.09
Cash & Short-term Investments1.00
Accounts receivable0.96
Inventories1.69
Other Current Assets0.01
Prepaid Expense And Other Assets Current0.18
Total Current Assets3.92
Equipment/Property/Plant Net2.52
Intangible Assets0.52
Other Assets, Noncurrent0.00
Deposits And Other Assets0.03
Total Assets5.06
Liabilities
Accounts Payable, Current AC0.31
Accrued Liabilities, Current AC0.97
Notes Payable, Current NO3.26
Other Liabilities, Current0.45
Total Current Liabilities4.98
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
OperatingLeaseLiabilityNoncurrent-
Advances From Nonaffiliated Collaboration0.25
Total Liabilities4.98
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock107.15
Retained Earnings / Accumulated Deficit-111.39
Other Equity0.00
Common Stockholder's Equity-4.23
Preferred Stockholder's Equity0.00
Non-controlling interests & other0.00
Total Stockholder's Equity-4.23
Liabilities & Stockholder's Equity5.06
4 historic quarters locked

Sign in to unlock the full International Stem Cell balance sheet history.

About International Stem Cell Corp Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-349108

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.